Jpmorgan Chase & CO Amyris, Inc. Transaction History

Jpmorgan Chase & CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.58 - $1.3 $56,158 - $125,872	96,825 Added 5.92%	1,733,667 $1.79 Million
Q1 2023 May 18, 2023	BUY	$1.09 - $1.82 $307,669 - $513,724	282,266 Added 20.84%	1,636,842 $2.23 Million
Q1 2023 May 11, 2023	SELL	$1.09 - $1.82 $824,404 - $1.38 Million	-756,334 Reduced 35.83%	1,354,576 $1.84 Million
Q4 2022 Feb 13, 2023	SELL	$1.52 - $3.39 $467,781 - $1.04 Million	-307,751 Reduced 12.72%	2,110,910 $3.23 Million
Q3 2022 Nov 14, 2022	SELL	$1.7 - $4.05 $221,188 - $526,949	-130,111 Reduced 5.1%	2,418,661 $7.06 Million
Q2 2022 Aug 11, 2022	SELL	$1.6 - $5.07 $680,459 - $2.16 Million	-425,287 Reduced 14.3%	2,548,772 $4.72 Million
Q1 2022 May 11, 2022	BUY	$3.92 - $5.86 $1.94 Million - $2.91 Million	495,885 Added 20.01%	2,974,059 $13 Million
Q4 2021 Feb 10, 2022	BUY	$5.0 - $14.85 $10.8 Million - $32.2 Million	2,167,308 Added 697.18%	2,478,174 $13.4 Million
Q3 2021 Nov 12, 2021	BUY	$12.13 - $16.99 $3.77 Million - $5.28 Million	310,866 New	310,866 $4.27 Million

230K

Ticker AMRS
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 324,860,000
Market Cap $3.25M
Description
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.